There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
I would stay away from Eli Lilly & Co. for now, though I anticipate a bearish move. There is still a chance for the company to recover, should they find a replacement and market it effectively. Even at that, they would still have a large burning hole...
Christian Siriano brings on creatures of the night With winged dresses and swirls of piping to evoke veins, Christian Siriano paid homage at New York Fashion Week to Fay Wray and vampire bats in a stark, cavernous runway space worthy of the creatures...
Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday... View Photo »
Inexpensive but people like other companies. I like Bristol-Myers Squibb (BMY) and Sanofi-Aventis (SNY) for yield.
Kate Nautiyal and Brian Bulthuis announce their engagement and plans for an October wedding. Both graduated from Columbia University in New York City. Brian now works for a trading firm in New York and Kate is teaching neuroscience at the University. ...
“The benefit of these organizations and programs lies in their ability to empower people in local communities with knowledge about prevention, diagnosis and care of hepatitis C and hepatitis B,” said John Damonti, president, Bristol-Myers Squibb...
Incoming Teva CEO Jeremy Levin attends a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Shlomo Yanai would step down as president and chief executive officer in May. View Photo »
This year marks the third time Bristol-Myers Squibb is sponsoring the ‘Fight HIV Your Way’ contest, an innovative program that continues to encourage people infected with or affected by HIV to keep fighting and to join us in our fight to help reduce the stigma for people living with HIV
Gilead Sciences Inc. (NASDAQ:GILD) shares dropped more than 16 percent this morning. The company announced unsuccessful results with its hepatitis C GS-7977 drug, which it acquired last month from the $11 billion purchase of Pharmasset Inc. Big...
Feb 17 (Reuters) - Bristol-Myers Squibb Co has received a subpoena from U.S. prosecutors seeking information about marketing of its widely sold Abilify drug for schizophrenia and depression. The U.S. attorney's office for the Southern District of New...
Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were graduates of Hamilton College), and E.R. Squibb Corporation. The New York... Full Article
Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Yanai would step down as...
View Photo »Incoming Teva CEO Jeremy Levin attends a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Shlomo Yanai would step down as president and chief executive officer in May. Yanai will be replaced by...
View Photo »ExonHit Chief Executive Loic Maurel attends the Reuters Biotech Forum in Paris June 9, 2011. ExonHit's neuropathic pain product licensed to Allergan and Bristol-Myers Squibb has moved to mid-stage trials, marking a significant milestone for the French biotech, Maurel said. To match...
View Photo »Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Yanai would step down as...
View Photo »Inexpensive but people like other companies. I like Bristol-Myers Squibb (BMY) and Sanofi-Aventis (SNY) for yield.
Together, Bristol-Myers Squibb and Alvin Ailey American Dance Theater are celebrating the inspiring stories of our first place winners and raising awareness in support of people living with HIV.
I know from my experience on the stage that the performing arts are vital in shedding light and bringing to life the real stories of those touched by HIV, and that is why I am excited to be involved in Bristol-Myers Squibb’s ‘Fight HIV Your Way’ initiative for the third time
This year marks the third time Bristol-Myers Squibb is sponsoring the ‘Fight HIV Your Way’ contest, an innovative program that continues to encourage people infected with or affected by HIV to keep fighting and to join us in our fight to help reduce the stigma for people living with HIV
